Mirum Pharmaceuticals Inc (MIRM)
EBITDA Margin
-125.68%
TTM · Period ending:
MIRM EBITDA Margin
Latest reported-125.68%period ending
Latest reported-125.68%period ending
MIRM TTM EBITDA Margin (-1296.96% → -125.68%)
TTM ebitda margin
High-resolution chart · PNG
MIRM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -125.6802% | |
| -133.6417% | |
| 2.6769% | |
| -1.1626% | |
| -4.3788% | |
| -9.9032% | |
| -14.5366% | |
| -19.7435% | |
| -27.7915% | |
| -56.9443% | |
| -73.2345% | |
| -97.2292% | |
| -133.2162% | |
| -119.5504% | |
| -158.9876% | |
| -57.6644% | |
| -105.8914% | |
| -158.6107% | |
| -341.6553% | |
| -1,016.0375% | |
| -1,296.9636% |